Legal Notice

Update September 14,2020

Today marks another low point in our dealings with Novohealthnet Limited, a subsidiary of Novo Integrated Sciences ( NVOS ) a publicly traded company. Having exhausted every reasonable course of action, after being met by complete silence on Novo’s part, this while incurring significant legal fees, we continue to take action.

The latest infraction by Novo consists in misappropriation of our funds further to the sale of our corporation in July 2019. In this latest instance, Novo cashed in and retained, thereby effectively misappropriating receivable funds from Action Plus. This latest infraction is one of many, including, default over payment of a substantial portion of the purchase price and infringements on the licensing agreement of our trade name. The later infraction is most concerning, as one should have reasonable concerns, in light of the conduct listed above, in the implications for our trade name.

Mr. Roberto Mattachionne is the acting CEO of Novo Integrated Sciences. We have previously concluded a sale of part of our operations to CBI Health 2009, and based on such experience, can confirm the sale to NovoHeatlhnet as most unusual. Acting reasonably, we continue our due diligence in reviewing these events and as we have previously done so, call on Mr. Mattachione for greater accounting in the details of his curriculum vitae, in particular his listed offshore accomplishments in South America and Africa. Should such details become available, we shall, amend this request.

July 23 2020 Update

As of the close of business today, Novo Healthnet limited has not communicated with nor has it delivered the share portion to Action Plus Physiotherapy, which formed part of the APA dated July 22 2019, these to be delivered at the 1 ( one ) year anniversary of the APA on July 22 2020.

Notwithstanding outstanding breaches in the APA listed below, this recent event is an added concern, and provides further evidence of non-compliance to the APA by Novo Healthnet. The absence of any meaningful response by Novo Healthnet management throughout these events is of significant concern. For these reasons we have no option but to terminate the licensing agreement in the use of our trade name and will move forward to recover unnecessary expenses and damages arising from this issue in the most expedient manner.

Of note the previous default condition pre-existed the Covid-19 pandemic.

Without Prejudice
November 18, 2019


By Asset Purchase Agreement and License Agreement dated July 22, 2019, Action Plus Physiotherapy (“Action Plus”) sold its Rockland clinic (the “Clinic”) to Novo Healthnet Limited (“Novo”).

As a term of the License, Action Plus granted a license to Novo to use the name “Action Plus Physiotherapy” in association with the Clinic.

Unfortunately, Novo is in breach of the terms of the Asset Purchase Agreement and the License.

Accordingly, Action Plus has demanded and continues to demand that Novo comply fully with all terms of the Asset Purchase Agreement and reimburse Action Plus for the damages and expenses it has suffered as a result of Novo’s non-compliance.

Further, until Novo is in full compliance with the Asset Purchase Agreement, Action Plus has demanded that Novo cease all use of the name “Action Plus” in any manner, place or media.